Urinary Bladder Neoplasm

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2023-03-28
Clinical Trial Update: A Single-Arm Study of Bempegaldesleukin (NKTR-214) Plus Nivolumab in Cisplatin Ineligible Patients Who Have Locally Advanced or Metastatic Urothelial Cancer [Phase 2]
Phase 2 single-arm study of bempegaldesleukin (NKTR-214) with nivolumab in cisplatin-ineligible, locally advanced or metastatic urothelial c…